Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Gina Kruse

Concepts (245)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Smoking Cessation
18
2025
437
6.660
 Why?
Early Detection of Cancer
9
2026
482
2.730
 Why?
Text Messaging
5
2023
182
2.240
 Why?
Tobacco Use
4
2026
62
1.930
 Why?
Tobacco Use Cessation
3
2025
28
1.790
 Why?
Smoking
9
2026
1470
1.780
 Why?
Electronic Nicotine Delivery Systems
7
2026
108
1.290
 Why?
Primary Health Care
7
2023
1725
1.240
 Why?
Massachusetts
9
2026
180
1.180
 Why?
HIV Infections
9
2026
3186
1.040
 Why?
Smokers
4
2020
136
1.000
 Why?
Varenicline
2
2025
28
0.960
 Why?
Tobacco Products
3
2025
84
0.950
 Why?
Uterine Cervical Neoplasms
3
2025
268
0.950
 Why?
Colorectal Neoplasms
4
2025
864
0.920
 Why?
Tobacco Use Disorder
3
2022
216
0.910
 Why?
Behavior Therapy
3
2025
294
0.910
 Why?
Opioid-Related Disorders
4
2026
600
0.890
 Why?
Intention
1
2026
186
0.820
 Why?
Peer Group
1
2026
252
0.790
 Why?
Postal Service
2
2020
27
0.790
 Why?
Buprenorphine
2
2025
190
0.790
 Why?
Laboratories
1
2023
110
0.710
 Why?
Lung Neoplasms
2
2026
2662
0.710
 Why?
Community Health Services
2
2015
231
0.710
 Why?
Social Support
1
2026
645
0.690
 Why?
United States Indian Health Service
2
2022
45
0.660
 Why?
India
4
2026
213
0.650
 Why?
Humans
66
2026
145140
0.640
 Why?
Alaska Natives
1
2022
101
0.640
 Why?
Patient Discharge
3
2024
991
0.630
 Why?
Health Knowledge, Attitudes, Practice
3
2026
1415
0.630
 Why?
Mentoring
1
2023
165
0.610
 Why?
Middle Aged
28
2026
36126
0.590
 Why?
Electronic Health Records
4
2016
1188
0.590
 Why?
Adult
33
2026
40665
0.560
 Why?
Papillomavirus Infections
1
2023
343
0.560
 Why?
Cross-Sectional Studies
13
2026
5886
0.550
 Why?
Health Behavior
3
2022
787
0.550
 Why?
Female
41
2026
78636
0.540
 Why?
Delivery of Health Care
4
2023
946
0.540
 Why?
Community Health Centers
5
2025
59
0.530
 Why?
Male
36
2026
72664
0.520
 Why?
Pilot Projects
6
2025
1889
0.510
 Why?
Telemedicine
3
2025
956
0.510
 Why?
Hospitalization
4
2025
2458
0.500
 Why?
Indians, North American
1
2022
598
0.490
 Why?
Meaningful Use
1
2016
13
0.490
 Why?
Rural Population
3
2024
657
0.480
 Why?
Commerce
2
2026
80
0.450
 Why?
Comorbidity
2
2017
1657
0.440
 Why?
Motivation
2
2019
600
0.440
 Why?
Smoke-Free Policy
1
2014
13
0.430
 Why?
Smoking Prevention
1
2015
166
0.420
 Why?
Unnecessary Procedures
1
2014
54
0.410
 Why?
Tobacco Smoking
2
2024
26
0.390
 Why?
Opiate Substitution Treatment
3
2025
186
0.390
 Why?
Reimbursement, Incentive
1
2013
42
0.380
 Why?
Program Development
1
2015
368
0.380
 Why?
Counseling
4
2024
400
0.380
 Why?
Vaping
2
2025
69
0.370
 Why?
United States
13
2026
16065
0.370
 Why?
Tobacco Smoke Pollution
1
2014
227
0.360
 Why?
Colonoscopy
1
2014
262
0.350
 Why?
Health Equity
3
2024
133
0.340
 Why?
Telephone
2
2023
177
0.340
 Why?
Documentation
1
2013
199
0.340
 Why?
Population Surveillance
1
2014
484
0.330
 Why?
Aged
15
2026
26096
0.320
 Why?
Neoplasms
2
2023
2900
0.320
 Why?
Prevalence
5
2026
2855
0.290
 Why?
Boston
4
2026
93
0.290
 Why?
Anti-HIV Agents
2
2014
908
0.280
 Why?
Alcoholism
2
2025
819
0.280
 Why?
Qualitative Research
4
2026
1671
0.270
 Why?
Randomized Controlled Trials as Topic
3
2025
1742
0.260
 Why?
Referral and Consultation
2
2012
862
0.260
 Why?
Students
2
2022
650
0.240
 Why?
Tobacco, Smokeless
1
2026
13
0.240
 Why?
Oklahoma
1
2026
21
0.240
 Why?
Cotinine
1
2026
76
0.230
 Why?
Flavoring Agents
1
2025
10
0.230
 Why?
Alcohol Deterrents
1
2025
26
0.220
 Why?
South Africa
2
2024
266
0.220
 Why?
Appointments and Schedules
2
2002
96
0.210
 Why?
Feasibility Studies
2
2022
1109
0.210
 Why?
Faculty
2
2022
147
0.200
 Why?
Pandemics
3
2021
1703
0.200
 Why?
Occult Blood
1
2024
40
0.200
 Why?
Patient Compliance
2
2012
587
0.200
 Why?
Outpatients
2
2024
447
0.200
 Why?
Substance Withdrawal Syndrome
1
2025
185
0.190
 Why?
Mental Disorders
2
2002
1154
0.190
 Why?
Social Determinants of Health
2
2024
307
0.190
 Why?
Vaginal Smears
1
2023
54
0.190
 Why?
Health Policy
1
2026
400
0.190
 Why?
Cost-Benefit Analysis
1
2025
640
0.190
 Why?
Narcotic Antagonists
1
2025
202
0.190
 Why?
Safety-net Providers
1
2024
129
0.180
 Why?
Cooperative Behavior
1
2025
461
0.180
 Why?
Papillomaviridae
1
2023
115
0.180
 Why?
Outpatient Clinics, Hospital
1
2002
80
0.180
 Why?
Interrupted Time Series Analysis
1
2022
75
0.180
 Why?
Treatment Refusal
1
2002
98
0.180
 Why?
Medically Underserved Area
1
2022
100
0.180
 Why?
Student Run Clinic
1
2021
3
0.170
 Why?
Tuberculosis
1
2024
283
0.170
 Why?
Internet
1
2026
689
0.170
 Why?
Mass Screening
3
2025
1354
0.170
 Why?
Patient Participation
1
2005
437
0.170
 Why?
Pain Management
1
2005
409
0.160
 Why?
Medication Adherence
1
2025
540
0.160
 Why?
Education, Medical, Undergraduate
1
2023
207
0.150
 Why?
Developing Countries
2
2015
316
0.150
 Why?
Community Networks
1
2020
57
0.150
 Why?
Physician-Patient Relations
1
2005
587
0.150
 Why?
Longitudinal Studies
2
2020
2949
0.150
 Why?
Education, Medical
1
2023
274
0.150
 Why?
Ambulatory Care
1
2024
608
0.150
 Why?
Pain
1
2005
781
0.150
 Why?
Interviews as Topic
3
2019
907
0.150
 Why?
Crisis Intervention
1
2019
37
0.150
 Why?
Young Adult
7
2025
14176
0.150
 Why?
Preventive Health Services
1
2020
153
0.140
 Why?
Analgesics, Opioid
2
2024
1145
0.140
 Why?
Nevirapine
2
2008
18
0.140
 Why?
Cohort Studies
5
2025
5988
0.130
 Why?
Students, Medical
1
2023
376
0.130
 Why?
Organophosphonates
2
2008
95
0.130
 Why?
Decision Making
1
2005
974
0.130
 Why?
Surveys and Questionnaires
4
2019
6055
0.130
 Why?
Liver Transplantation
1
2024
826
0.120
 Why?
Deoxycytidine
2
2008
220
0.120
 Why?
Adolescent
8
2025
22479
0.120
 Why?
Licensure
2
2026
16
0.120
 Why?
Communication
1
2023
973
0.120
 Why?
Pneumonia, Viral
1
2021
388
0.120
 Why?
Texas
4
2005
272
0.120
 Why?
Infectious Disease Transmission, Vertical
2
2008
194
0.120
 Why?
Diabetes Mellitus
1
2024
1092
0.120
 Why?
Hypertension
1
2024
1269
0.120
 Why?
Diffusion of Innovation
1
2016
96
0.120
 Why?
Adenine
2
2008
338
0.110
 Why?
Tomography, X-Ray Computed
1
2026
2767
0.110
 Why?
Focus Groups
2
2022
569
0.110
 Why?
Allied Health Personnel
1
2015
53
0.110
 Why?
Caregivers
1
2024
1070
0.110
 Why?
Health Surveys
1
2017
517
0.110
 Why?
Automobiles
1
2014
18
0.110
 Why?
Logistic Models
3
2017
2133
0.100
 Why?
Uganda
1
2014
89
0.100
 Why?
Community Health Workers
1
2015
88
0.100
 Why?
Colonic Polyps
1
2014
85
0.100
 Why?
Odds Ratio
3
2008
1082
0.100
 Why?
Program Evaluation
2
2020
943
0.100
 Why?
Residence Characteristics
2
2014
373
0.100
 Why?
Research Design
1
2019
1132
0.090
 Why?
Managed Care Programs
1
2013
140
0.090
 Why?
Patient Admission
1
2014
220
0.090
 Why?
Hospitals, Psychiatric
2
2002
29
0.090
 Why?
Stress, Psychological
1
2021
1145
0.090
 Why?
Social Class
1
2014
264
0.090
 Why?
Nurses
1
2014
171
0.090
 Why?
Prospective Studies
3
2025
8035
0.090
 Why?
HIV-1
2
2008
906
0.090
 Why?
Patient Acceptance of Health Care
3
2022
881
0.090
 Why?
Feedback
1
2012
180
0.090
 Why?
Health Services Accessibility
4
2024
1099
0.090
 Why?
Health Plan Implementation
1
2012
141
0.080
 Why?
Quality Assurance, Health Care
1
2013
342
0.080
 Why?
Retrospective Studies
5
2025
17247
0.080
 Why?
Follow-Up Studies
2
2024
5411
0.080
 Why?
Emergency Service, Hospital
1
2022
2377
0.080
 Why?
Hospitals
1
2014
732
0.070
 Why?
Diabetes Mellitus, Type 2
1
2022
2578
0.070
 Why?
Reverse Transcriptase Inhibitors
1
2007
87
0.060
 Why?
Chronic Disease
1
2013
1806
0.060
 Why?
Drug Resistance, Viral
1
2007
124
0.060
 Why?
Taxes
1
2026
16
0.060
 Why?
Patient Care Team
1
2012
696
0.060
 Why?
Renal Insufficiency
1
2008
172
0.060
 Why?
Anti-Retroviral Agents
1
2008
251
0.060
 Why?
Behavioral Risk Factor Surveillance System
1
2025
57
0.060
 Why?
Risk Factors
2
2014
10857
0.060
 Why?
Regression Analysis
2
2005
998
0.060
 Why?
Insurance, Health
2
2005
310
0.050
 Why?
Aged, 80 and over
4
2024
8318
0.050
 Why?
Naltrexone
1
2025
115
0.050
 Why?
Insurance Coverage
2
2022
244
0.050
 Why?
Vaccination
2
2022
1423
0.050
 Why?
Drug Therapy, Combination
2
2022
1043
0.050
 Why?
Pregnancy Complications, Infectious
1
2008
438
0.050
 Why?
Quality Improvement
1
2012
1293
0.050
 Why?
Housing
1
2024
142
0.050
 Why?
Social Networking
1
2023
32
0.050
 Why?
Mobile Health Units
1
2022
20
0.050
 Why?
Rural Health Services
1
2004
138
0.050
 Why?
Midwestern United States
1
2002
44
0.050
 Why?
Health Services for the Aged
1
2003
72
0.050
 Why?
Pragmatic Clinical Trials as Topic
1
2022
132
0.040
 Why?
Health Status
2
2005
832
0.040
 Why?
Hospitals, University
1
2002
176
0.040
 Why?
Stakeholder Participation
1
2022
83
0.040
 Why?
Bupropion
1
2022
48
0.040
 Why?
Antiviral Agents
1
2007
767
0.040
 Why?
Schools, Medical
1
2023
159
0.040
 Why?
Meals
1
2022
128
0.040
 Why?
Quality of Life
2
2022
3194
0.040
 Why?
Continuity of Patient Care
1
2004
296
0.040
 Why?
England
1
2021
108
0.040
 Why?
Vulnerable Populations
1
2022
175
0.040
 Why?
HIV
1
2022
251
0.040
 Why?
Data Collection
1
2024
639
0.040
 Why?
Hospital Mortality
1
2025
1038
0.040
 Why?
Minority Groups
1
2022
284
0.040
 Why?
Poverty
1
2024
525
0.040
 Why?
Length of Stay
1
2025
1348
0.040
 Why?
Urban Population
1
2003
492
0.040
 Why?
Triage
1
2021
250
0.030
 Why?
Learning
1
2023
443
0.030
 Why?
Age Factors
1
2026
3338
0.030
 Why?
Medicaid
1
2003
466
0.030
 Why?
Zambia
2
2008
58
0.030
 Why?
Treatment Outcome
1
2012
11741
0.030
 Why?
Medicare
1
2003
902
0.030
 Why?
Practice Guidelines as Topic
1
2025
1579
0.030
 Why?
Emtricitabine
2
2008
209
0.030
 Why?
Tenofovir
2
2008
300
0.030
 Why?
Curriculum
1
2023
1067
0.030
 Why?
Child
2
2024
22670
0.020
 Why?
Case-Control Studies
1
2017
3616
0.020
 Why?
Socioeconomic Factors
2
2004
1321
0.020
 Why?
Chi-Square Distribution
1
2008
527
0.020
 Why?
Antiretroviral Therapy, Highly Active
1
2008
279
0.020
 Why?
Creatinine
1
2008
513
0.020
 Why?
Risk
1
2008
916
0.010
 Why?
Proportional Hazards Models
1
2008
1325
0.010
 Why?
Pregnancy
2
2008
7182
0.010
 Why?
Glomerular Filtration Rate
1
2008
765
0.010
 Why?
Health Status Indicators
1
2004
167
0.010
 Why?
Office Visits
1
2003
92
0.010
 Why?
Health Care Surveys
1
2003
535
0.010
 Why?
Disease Progression
1
2008
2857
0.010
 Why?
Biomarkers
1
2008
4282
0.010
 Why?
Infant, Newborn
1
2007
6435
0.010
 Why?
Kruse's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (245) concept(s)
_
Co-Authors Expand Description
See all (20) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)